相关实验视频
Updated: May 13, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
先进技术在改善糖尿病结果中的作用
David G Marrero, Christopher G Parkin1, Grazia Aleppo
1CGParkin Communications, Inc, 2675 Windmill Pkwy, Ste 2721, Henderson, NV 89074.
The American journal of managed care
|April 14, 2025
概括
创新型糖尿病技术,如持续血糖监测 (CGM) 和自动胰岛素输送 (AID),可以改善结果并降低成本. 基于价值的护理模式对于所有患者的平等获取和更好的糖尿病管理至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 医疗保健服务研究 医疗服务研究
- 卫生经济学 卫生经济学
背景情况:
- 美国目前的糖尿病护理面临的挑战是为大多数人实现最佳的血糖控制.
- 创新技术,如持续血糖监测 (CGM) 和自动胰岛素输送 (AID) 系统,为糖尿病管理提供了显著的潜在好处.
研究的目的:
- 评估目前美国糖尿病护理的情况.
- 评估先进糖尿病技术的价值和可访问性.
- 探索基于价值的护理模式对糖尿病结果和成本的影响.
主要方法:
- 对美国糖尿病护理当前状况进行了叙事审查.
- 该审查包括对使用CGM和AID系统等糖尿病技术的分析.
- 通过互联网搜索,确定了相关的研究和政府报告.
主要成果:
- 研究表明,CGM和AID改善了血糖控制,减少了与糖尿病有关的事件,并降低了医疗保健利用率和成本.
- 尽管证明有好处,但许多糖尿病患者无法达到他们的血糖目标.
- 由于限制性资格标准,种族/民族少数群体和社会经济地位较低的社区在技术获取和使用方面存在重大差异.
结论:
- 过渡到以价值为基础的糖尿病护理模式符合五重目标框架.
- 采取主动的,以价值为基础的方法可以提高患者的治疗结果,改善生活质量,并减少长期糖尿病护理支出.
- 从收费服务模式转向以价值为基础的护理对于改善糖尿病管理和降低医疗保健成本至关重要.
相关概念视频
Diabetes: Management and Pharmacotherapy
213
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
213
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Issues And Trends In Healthcare Delivery System
5.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.5K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
141
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
141
Diabetes: Symptoms, Diagnosis, and Complications
485
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
485

